The alo1 gene of Schizosaccharomyces pombe encodes a predicted enzyme D-arabinono-1,4-lactone oxidase (ALO)[1]. This enzyme is proposed to catalyze the final oxidation step in the biosynthesis of D-erythroascorbic acid, a five-carbon analog of vitamin C (L-ascorbic acid) found in fungi[2]. In fungi such as yeast, ALO converts D-arabinono-1,4-lactone to D-erythroascorbate, establishing an antioxidant system parallel to the ascorbic acid pathways of plants and animals[2]. Despite this annotated role, alo1 has not been experimentally characterized in fission yeast. Uncovering its molecular function and biological role is important, as clues from other organisms suggest alo1 may impact oxidative stress resistance, metabolism, and organelle function. Below, we critically review known and predicted features of alo1 – drawing from databases (PomBase, UniProt) and comparative biology – and then propose a hypothesis-driven experimental plan to elucidate alo1’s function in S. pombe. Key gaps in knowledge are highlighted, and targeted approaches are outlined to address these gaps.
Enzymatic activity: alo1 is predicted to encode a flavin adenine dinucleotide (FAD)-dependent oxidoreductase that uses oxygen to oxidize D-arabinono-1,4-lactone[2][3]. This reaction yields D-erythroascorbic acid (EASC), an antioxidant analogous to L-ascorbate (vitamin C)[2]. Notably, alo1 is orthologous to the Saccharomyces cerevisiae ALO1 gene, which was biochemically confirmed to catalyze EASC production[4][5]. In S. cerevisiae, ALO1 was purified and shown to create the redox-active enediol structure of erythroascorbate, similar to how L-gulonolactone oxidase (GULO) produces ascorbate in animals[6][2]. Consistent with this, S. pombe Alo1 is classified in the same aldonolactone oxidoreductase family as GULO and plant L-galactono-1,4-lactone dehydrogenase (GalDH)[7]. All these enzymes share a common mechanism: oxidation at the C2 hydroxyl of a sugar lactone to form a C2=C3 double bond, which is essential for antioxidant activity[8].
Protein features: The Alo1 protein (461 amino acids) contains conserved domains characteristic of FAD-linked oxidases: an N-terminal FAD-binding domain and a C-terminal ALO domain[9][10]. The FAD cofactor is likely covalently attached to Alo1 – S. cerevisiae ALO1 has a conserved histidine that binds FAD, and sequence analysis revealed a “covalent FAD-binding site” in the enzyme[11]. This covalent flavin is a hallmark of the vanillyl-alcohol oxidase family to which ALO1 belongs[7]. Additionally, Alo1 is predicted to be an integral membrane flavoprotein: it has a hydrophobic segment near the C-terminus that likely anchors it to a membrane[11]. PomBase and UniProt annotations indicate Alo1 localizes to the mitochondrial membrane[12]. In budding yeast, ALO1 was found associated with the outer mitochondrial membrane, exposing most of the protein to the cytosol[13][14]. We anticipate S. pombe Alo1 is similarly membrane-anchored, which would position the active site at the mitochondrial surface where it can access cytosolic D-arabinono-1,4-lactone. The oxygen-dependent nature of the reaction suggests Alo1 contributes to non-respiratory oxygen utilization in the cell. Notably, the enzyme may produce hydrogen peroxide (H₂O₂) as a by-product (as animal GULO does), linking Alo1 activity to cellular redox balance.
Substrate scope and mechanism: Based on homology, Alo1 is expected to have a somewhat broad substrate specificity for lactone sugars. The S. cerevisiae enzyme not only oxidizes D-arabinono-1,4-lactone (to EASC) but can also oxidize analogs like L-gulono-1,4-lactone and L-galactono-1,4-lactone in vitro[15]. This suggests the catalytic pocket recognizes the lactone ring rather than specific stereochemistry of the entire molecule. The ability to act on L-gulonolactone is especially intriguing, as it implies fungal ALO could theoretically produce L-ascorbate under engineered conditions[15]. Mechanistically, Alo1 is a two-electron oxidase: it likely transfers electrons from the substrate to its FAD, and then from reduced FAD to oxygen, forming H₂O₂[8]. However, structural studies show that small amino acid changes can convert an oxidase into a dehydrogenase that uses alternative electron acceptors[16]. In the aldonolactone oxidoreductase family, a single “flavin-interacting” residue modulates preference for oxygen vs. cytochrome c[16]. It would be insightful to identify this residue in Alo1’s sequence; given that fungi use O₂ as acceptor, Alo1 likely has the variant that favors oxidase activity. Overall, the molecular function of Alo1 in S. pombe is strongly inferred to be a D-arabinono-1,4-lactone:oxygen oxidoreductase (EC 1.1.3.37) that produces an antioxidant, with structural adaptations (flavin binding and membrane anchor) to operate in the mitochondrial context.
Although alo1’s biochemistry is predicted by homology, its physiological role in S. pombe remains to be demonstrated. Studies in other fungi provide important clues. In S. cerevisiae, ALO1 is essential for endogenous erythroascorbate production – alo1Δ mutants completely lack D-erythroascorbic acid and ALO activity[5]. Loss of ALO1 in budding yeast leads to heightened sensitivity to oxidative stress (e.g. H₂O₂ exposure)[17]. Conversely, overexpressing ALO1 increases cellular EASC levels \~7-fold and confers greater resistance to oxidants[5]. This establishes that the antioxidant function of ALO1 is physiologically important, protecting yeast from oxidative damage. We expect S. pombe alo1 to play a similar role in oxidative stress defense. Consistent with this, alo1 is categorized under “oxidative stress response” genes in high-throughput studies[18]. Furthermore, alo1 might be regulated by cellular oxygen and stress conditions. In S. pombe, the Sre1 hypoxia pathway controls many non-respiratory oxygen-utilizing enzymes[19]; it is plausible that alo1 expression is down-regulated anaerobically and up-regulated when oxygen is available for antioxidant biosynthesis (though direct data are lacking and warrant testing).
Beyond single-cell stress survival, fungal ALO1 homologs impact complex phenotypes. In the plant-pathogenic fungus Magnaporthe oryzae, deletion of the ALO1 ortholog (MoALO1) caused severe defects in growth and development – the mutant grew slower, produced fewer conidia (asexual spores), and had impaired appressorium formation[20]. Strikingly, Moalo1 mutants also showed diminished virulence, failing to infect rice normally[21]. These defects were attributed to loss of EASC: the ΔMoalo1 strain was hypersensitive to H₂O₂, and supplying exogenous D-erythroascorbate restored its pathogenicity to wild-type levels[22]. Thus, fungal ALO1 is not only an antioxidant enzyme but can be crucial for stress endurance during host infection. Similarly, in Candida albicans (a human pathogen), ALO1 is important for survival under host-derived oxidative stress – C. albicans alo1Δ mutants show attenuated hyphal growth and virulence[23]. These findings suggest that ALO1-mediated EASC production is a conserved strategy in fungi to withstand oxidative challenges, whether from the environment or immune system.
It is worth noting that higher eukaryotes have analogous enzymes, underscoring a broader evolutionary conservation. Animals synthesize ascorbic acid using GULO (absent in humans due to mutation), and plants synthesize ascorbate via GalDH; these enzymes share significant sequence identity with yeast Alo1 (e.g. \~32% identity to rat GULO)[11]. Phylogenetic analysis confirms that ALO, GULO, and GalDH evolved from a common ancestral enzyme, diverging to meet the metabolic demands of different lineages[2][7]. The core FAD-binding fold and catalytic residues are conserved from fungi to mammals[7]. For example, Alo1 shares the signature GGXW motif of FAD-dependent oxidases and likely the histidyl-FAD linkage seen in VAO-family enzymes[11]. Alignment of ALO1 homologs across species (yeasts, filamentous fungi, plants, animals) shows they all contain the FAD-binding_4 domain and the ALO-specific C-terminal region[10]. This conservation suggests that S. pombe Alo1 will have a structure and mechanism closely resembling those of its fungal and metazoan counterparts, reinforcing our functional predictions.
An unexpected facet of ALO1 biology emerged from a recent study in S. cerevisiae: Alo1 appears to moonlight in mitochondrial inheritance. Chelius et al. (2025) identified Alo1 in a screen for proteins that bind the type V myosin motor Myo2 (which transports organelles along actin)[24]. Alo1 was found anchored in the mitochondrial outer membrane and capable of recruiting Myo2 to mitochondria[14]. Intriguingly, deletion of ALO1 in budding yeast caused abnormal mitochondrial morphology and distribution between mother and daughter cells, especially under oxidative stress[14]. Overexpression of ALO1 could even counteract the stress-induced retention of mitochondria in mother cells[25]. These results suggest Alo1 links mitochondria to the actin-based transport machinery, aiding their equal partitioning, particularly when oxidative damage might otherwise immobilize the organelles. It is unknown whether S. pombe Alo1 has a similar role – fission yeast divide by medial fission (not budding) and use different myosin motors (Myo52 is the class V myosin for cargo transport). However, this raises exciting questions about Alo1’s potential multifunctionality. In S. pombe, mitochondrial inheritance relies on proper transport and anchoring of organelles during cell division; if Alo1 or its binding partners contribute to this process, alo1 deletion might subtly affect mitochondrial positioning or segregation in stressed cells. No such phenotype has been reported yet, but our experimental plan will consider assays to reveal any organelle dynamics role for Alo1.
Summary of gaps: In summary, S. pombe alo1 is strongly predicted to encode a D-arabinonolactone oxidase producing an ascorbate analog and contributing to oxidative stress resistance. This is bolstered by cross-species evidence of its enzymatic activity and stress-protective function. However, alo1 has not been directly studied in fission yeast: we lack data on its loss-of-function phenotype, biochemical activity in vivo, regulation, protein interactors, and subcellular details. It is also unclear if Alo1 has any non-enzymatic roles (e.g. in organelle maintenance) in S. pombe. These gaps motivate a comprehensive experimental approach to characterize alo1. Below, we outline a hypothesis-driven research plan to determine alo1’s function, combining genetic, cell biological, biochemical, and structural methods.
Overview: We propose a multifaceted strategy to define alo1’s role: firstly by creating alo1 loss-of-function strains and characterizing their phenotype, then by probing genetic interactions and cellular processes that alo1 might influence, and finally by biochemically verifying Alo1’s activity and structure. The working hypothesis is that alo1 encodes an enzyme required for antioxidant (erythroascorbate) production, which in turn protects cells from oxidative damage. We also hypothesize alo1 may interface with mitochondrial function (localization or inheritance). Each set of experiments below is designed to test specific predictions or reveal new functions:
Generate alo1 Null Mutants and Assess Viability and Stress Phenotypes: We will delete the alo1 gene in S. pombe (by homologous recombination replacing it with a marker) to obtain a clean alo1Δ strain. If alo1 is essential for viability (unlikely given other fungi survive its loss[20]), we will instead create a conditional knockdown or an inducible promoter swap. The knockout strain will be examined for baseline growth and morphology under normal conditions to see if alo1 is required for optimal proliferation. Given Magnaporthe results, we will check for any growth defect on rich media and minimal media. Next, we will test the mutant’s sensitivity to oxidative stress. Spot dilution assays and growth curves will be performed with oxidants such as H₂O₂ and menadione (a superoxide generator). We expect alo1Δ cells to show reduced growth or viability compared to wild type when challenged with reactive oxygen species, reflecting loss of the EASC antioxidant. We will quantify survival fractions after acute peroxide exposure and measure any increase in protein oxidation or lipid peroxidation markers in the mutant. If alo1 indeed confers oxidative stress protection, the knockout should phenocopy S. cerevisiae alo1Δ (hypersensitive to oxidants)[17] and M. oryzae alo1Δ (H₂O₂-sensitive)[22]. As a control, we will complement the mutant by reintroducing alo1+ on a plasmid to see if it restores normal resistance. In addition, because alo1 might affect other stress responses, we will test alo1Δ under heat stress, osmotic stress, and nutrient starvation to uncover any broader role (e.g. if EASC protects during stationary phase). Phenotypic analyses will also include microscopic examination of cell morphology: cell length, septation, and any abnormalities in cell cycle progression or viability (e.g. via staining dead cells) to detect subtle effects. If Alo1 influences mitochondria, the mutant might display altered mitochondrial distribution or content; we will use a mitochondrial dye (e.g. MitoTracker) to see if alo1Δ cells have obvious mitochondrial morphology defects under normal or stress conditions. These initial phenotypes will establish the foundation for understanding alo1’s importance in vivo.
Epistasis and Genetic Interaction Analysis: To place alo1 in cellular pathways, we will perform targeted genetic interaction studies with other mutations. One approach is to combine alo1Δ with mutants in known oxidative stress regulators and antioxidants. For example, we will create double mutants of alo1Δ with Δpap1 (Pap1 is the AP-1-like transcription factor that induces antioxidant genes in S. pombe). If alo1 and pap1 function in parallel oxidative stress defense pathways, the double mutant might show synthetic sensitivity to oxidative stress far greater than either single mutant. Similarly, we can combine alo1Δ with deletions of enzymes like catalase (ctt1Δ, which degrades H₂O₂) or glutathione biosynthesis (gsh1Δ). Enhanced stress phenotypes or synthetic sickness in double mutants would indicate that Alo1’s antioxidant role is partly redundant with these systems. For instance, if alo1Δ ctt1Δ is inviable under air (oxygen exposure), it means erythroascorbate and catalase normally provide parallel protection against peroxide. On the other hand, if double mutants are no worse than single mutants, Alo1 likely functions in the same pathway as those genes (or is not a major contributor under the tested conditions). We will also examine genetic interactions relevant to mitochondrial health. Combining alo1Δ with a mutant that impairs mitochondrial antioxidant defenses (e.g. sod2Δ encoding mitochondrial superoxide dismutase) could reveal additive effects on mitochondrial ROS accumulation or mitochondrial DNA stability. Additionally, to probe the possible link to organelle transport, we could cross alo1Δ with a mutant in mitochondrial trafficking. S. pombe transports mitochondria along microtubules and actin; Myo52 (class V myosin) is involved in cargo transport to cell tips, and dnm1Δ (dynamin) causes a mitochondrial network collapse. If alo1 deletion exacerbates any mitochondrial distribution defect of these mutants, it might hint Alo1 has a supportive role in that process. Conversely, if alo1Δ rescues a phenotype (which is less likely), it could suggest an unforeseen antagonistic relationship. Beyond targeted crosses, we will employ an unbiased approach: a genome-wide synthetic lethal screen (e.g. via haploid deletion collections or CRISPR libraries) to find genes that become essential when alo1 is deleted. Any hits from such a screen might point to pathways that buffer the absence of Alo1. For example, we might discover that mutants in the glutathione system cannot tolerate alo1* loss, reinforcing that EASC and glutathione serve overlapping roles. Overall, the epistasis analyses will help position Alo1 within the cellular network of stress response and metabolism.
Cellular Localization and Organelle Dynamics: To verify and refine Alo1’s subcellular localization, we will tag the endogenous alo1 gene with a fluorescent protein (e.g. GFP) at the C-terminus (after the presumed transmembrane anchor). The functionality of the Alo1-GFP fusion will be confirmed by its ability to rescue the alo1Δ stress phenotype. Live-cell fluorescence microscopy will then be used to observe where Alo1 resides. We expect to see punctate or tubular signals co-localizing with mitochondria. Co-staining cells with MitoTracker or co-expressing a mitochondrial matrix marker (e.g. Rfp targeted to mitochondria) can demonstrate co-localization. If Alo1-GFP outlines the mitochondria similar to Tom20 (an outer membrane marker), it would confirm mitochondrial outer membrane localization as in budding yeast[14]. We will also perform biochemical fractionation: isolate mitochondria from cells and treat with protease in the absence vs. presence of detergents. If Alo1 is outer-membrane exposed, proteinase K should digest the GFP tag in intact mitochondria (rendering the fusion protein \~ lower molecular weight on a blot), whereas an inner membrane or matrix protein would be protected until membranes are solubilized. This protease protection assay will clarify which face of the membrane Alo1 occupies. Additionally, we will assess if Alo1’s localization or abundance changes under different conditions. For instance, does oxidative stress induce any relocalization or higher expression of Alo1-GFP? Using fluorescence intensity measurements or Western blotting, we can detect if H₂O₂ or oxygen shifts regulate the protein level or mitochondrial association (though alo1 is likely constitutively mitochondrial).
We will also investigate mitochondrial dynamics in the absence of Alo1, given the Myo2-interaction reported in budding yeast. Using time-lapse fluorescence microscopy (e.g. labeling mitochondria with matrix-targeted GFP in alo1Δ and wild type), we can track mitochondrial movement and segregation during the cell cycle. S. pombe normally partitions mitochondria between daughter cells during division; we will quantify if alo1Δ cells show any bias or delay in this partitioning. Under oxidative stress (e.g. treating cells with low doses of H₂O₂ during imaging), wild-type fission yeast might have a mechanism to retain damaged mitochondria on one side – does alo1Δ disrupt or exaggerate such behavior? We could also fluorescently mark one end of the cell’s mitochondria and see if movement to the other end is impaired without Alo1. If feasible, fluorescence recovery after photobleaching (FRAP) on mitochondrial fragments could measure transport rates along actin cables in alo1Δ vs. wild type. While these experiments are exploratory, any observed mitochondrial distribution defect in alo1Δ (especially under stress) would be a novel finding, suggesting alo1 in fission yeast, like in budding yeast, influences organelle dynamics. To complement this, we may test physical interaction between S. pombe Alo1 and myosin V (Myo52). Co-immunoprecipitation (see below) or a yeast two-hybrid assay between Alo1’s C-terminal domain and the cargo-binding domain of Myo52 can probe a direct interaction. A positive interaction would echo the S. cerevisiae result[14], indicating a conserved link between antioxidant machinery and organelle transport.
To complement the unbiased proteomics, we can perform direct assays for known candidate interactions. For example, we will test if Alo1 co-immunoprecipitates with Myo52-GFP or vice versa using specific antibodies. We will also test whether Alo1 physically associates with any subunits of mitochondrial contact site complexes or quality control machinery, as this could relate to how damaged mitochondria are handled. If our earlier epistasis tests suggested a genetic link between alo1 and other pathways (say, glutathione or Pap1), we could ask if Alo1 pulls down any glutathione S-transferases or Pap1 itself (perhaps unlikely, but worth checking if Pap1 might regulate or bind antioxidant enzymes). The outcome of these interaction studies will reveal whether Alo1 functions purely as a solitary enzyme or as part of a larger protein complex. Any novel interacting protein will direct further functional experiments – for instance, if we find Alo1 binds a specific mitochondrial outer membrane protein, we could test alo1Δ and that gene’s mutant for similar phenotypes, or see if one controls localization of the other.
In parallel, we will perform metabolomic analysis focusing on ascorbate and related metabolites. We will attempt to detect and quantify D-erythroascorbic acid in S. pombe cells. High-performance liquid chromatography (HPLC) coupled with UV detection or mass spectrometry can separate EASC from other sugars/acids. Using standards (possibly chemically synthesized D-erythroascorbate or purified from yeast), we will measure EASC levels in wild-type vs. alo1Δ. We expect wild-type fission yeast to contain measurable EASC (yeasts typically have 0.1–1 mM intracellular EASC[17]), whereas alo1Δ should have undetectable or drastically reduced EASC. This would be a direct confirmation of Alo1’s enzymatic product in S. pombe. If we detect EASC, we will also test how its levels change under stress (does the pool deplete upon oxidative challenge as it gets used to quench ROS, then rebound?). Moreover, we can feed cells with potential precursors to see if they enter the pathway. Feeding wild-type cells D-arabinose or D-arabinono-1,4-lactone might elevate EASC levels if the pathway is not saturated; alo1Δ cells fed these will likely just accumulate the lactone (which we can check by LC-MS). Metabolomics could also reveal if alo1Δ accumulates upstream metabolites (e.g. D-arabinono-lactone, D-arabinitol if present) or has altered glutathione redox state, etc. Collectively, the transcriptomic and metabolomic data will provide a systems-level view of how alo1 loss affects cell state and will either corroborate the expected role in redox homeostasis or hint at new roles (for instance, if unexpected pathways are misregulated in the mutant).
Biochemical Characterization of Alo1 Enzyme Activity: To conclusively demonstrate Alo1’s biochemical function, we will purify the Alo1 protein and assay its enzymatic activity in vitro. We plan to express S. pombe Alo1 recombinantly, likely in a yeast system (such as Pichia pastoris or even S. pombe itself) to ensure proper folding and FAD insertion. Because Alo1 is membrane-bound, we will express a version truncated for the transmembrane helix (e.g. last \~20 amino acids removed) and include a polyhistidine tag for purification. The recombinant protein (potentially still carrying FAD) will be purified by nickel affinity and gel filtration. We will test its activity on various lactone substrates: D-arabinono-1,4-lactone (the native substrate), and for comparison L-galactono-1,4-lactone and L-gulono-1,4-lactone. The enzyme assay can be done by measuring oxygen consumption (using an oxygen electrode) or by a coupled reaction detecting H₂O₂ formation (e.g. via horseradish peroxidase and a dye). We expect the enzyme to show robust oxidation of D-arabinonolactone with O₂, confirming its annotated EC 1.1.3.37 activity. If Alo1 is functional, we may observe it can also oxidize L-gulonolactone (suggesting some ability to produce L-ascorbate in vitro, aligning with the broad specificity noted for yeast ALO1[15]). Kinetic parameters (Km, Vmax) for each substrate will be determined to quantify how specialized the enzyme is for the D-arabino substrate. We will also test if the enzyme truly requires oxygen or if it can use alternative electron acceptors (for example, adding cytochrome c in the assay to see if any dehydrogenase activity is detectable – although in vivo it likely uses oxygen as shown by sequence features[16]). To validate that the purified enzyme’s activity corresponds to the in vivo function, we will see if cell extracts from wild-type and alo1Δ behave similarly: wild-type extracts should convert D-arabinono-lactone to EASC (we can monitor EASC formation by HPLC or a colorimetric ascorbate assay), whereas alo1Δ extracts should not. Additionally, we will measure the intracellular EASC in wild-type vs. alo1Δ as described above; rescuing alo1Δ with a catalytically dead version of Alo1 should fail to restore EASC, confirming the necessity of the enzymatic function. We will create point mutants in Alo1’s predicted active site (for instance, mutate the histidine that binds FAD, or other conserved catalytic residues gleaned from alignment with GULO/GalDH) and test these in vivo by expressing them in alo1Δ. If those mutants cannot complement the stress resistance or do not produce EASC, that verifies those residues are essential for activity (further proving that the antioxidant function of Alo1 underlies the phenotype). Finally, we might attempt to detect the FAD cofactor in Alo1. UV-visible absorbance of purified Alo1 protein (yellow color and absorbance \~450 nm) would indicate FAD bound; treating the protein with acid can release the flavin for HPLC identification. If the flavin is covalently attached, it may not release easily, confirming the covalent FAD linkage[11]. These biochemical assays will provide direct proof of Alo1’s enzymatic role and its catalytic properties, firmly assigning alo1 the function predicted by sequence.
Structural Modeling and Structural Biology: To gain insights into Alo1’s structure and to guide mutagenesis, we will leverage computational modeling and potentially solve the structure experimentally. An AlphaFold2 model of S. pombe Alo1 will be generated to predict its 3D conformation. We expect the model to reveal the typical two-domain architecture: a FAD-binding domain (likely an α/β fold binding FAD in an extended conformation) and a smaller helical domain (possibly containing the membrane anchor at its end)[11]. The model should position a conserved histidine near the flavin isoalloxazine ring, consistent with the 8α-histidyl-FAD found in related enzymes. We will validate the model by checking it against known structures: for instance, the recent structural study by Boverio et al. (2024) solved representative aldonolactone oxidoreductases[27], which we can use for comparison. If available, a crystal structure of S. cerevisiae ALO1 or an ancestor enzyme might exist from that study. We will align our model to any published structures (like rat GULO or plant GalDH which have known structures[2]). This will help identify active-site residues that determine substrate specificity and electron acceptor preference. For example, Boverio et al. showed that a flavin-interacting amino acid dictates oxidase vs. dehydrogenase behavior[16]. We will find the corresponding residue in Alo1’s model and confirm it matches the “oxidase-type” (likely a small residue that allows O₂ access to the flavin). We can test this by mutating Alo1 to the “dehydrogenase-type” residue and seeing if activity with oxygen decreases or if the mutant can partner with cytochrome c (though that would be a very exploratory experiment). The structural model will also highlight the substrate binding pocket. We will use docking simulations to see how D-arabinono-1,4-lactone likely sits in the active site. Key residues that hydrogen-bond to the lactone or position it for hydride transfer to FAD will be noted. These residues (for instance, a glutamate or tyrosine that might act as a general base to deprotonate the lactone) will be candidates for site-directed mutagenesis to probe their role. By creating point mutants (e.g. E→Q or Y→F) in the alo1 gene and testing enzyme activity in vitro or the ability to complement alo1Δ in vivo, we can validate the structural predictions. If a predicted catalytic residue mutation abolishes activity and fails to rescue antioxidant function, it strongly supports the structural model’s accuracy.
For an experimental structure, we will attempt X-ray crystallography on the soluble portion of Alo1 (after removing the tail anchor). We can utilize homology to known crystallized enzymes (perhaps co-crystallize Alo1 with a substrate analog or FAD). If crystals are hard to obtain, an alternative is cryo-electron microscopy (cryo-EM) given the protein is \~50 kDa (which might be borderline small for single-particle cryo-EM unless part of a larger complex). However, if Alo1 forms homodimers or higher oligomers (to be tested by gel filtration and crosslinking), that might aid cryo-EM. Another approach is to crystallize a close homolog: yeast ALO1s are similar enough that S. cerevisiae Alo1 (526 aa) could be tried; it was purified decades ago[4], so obtaining it in quantity is feasible. A structure would allow us to directly observe the active site geometry, the FAD attachment (covalent link evidence), and the membrane helix orientation. It would also let us visualize any surface patches that might mediate protein-protein interactions (e.g. where Myo2 might bind on Alo1, possibly the surface of the C-terminal domain).
Validation of the structural model will come from the biochemical experiments above (successful prediction of which mutants lose function) and possibly from spectroscopy. For example, if the model suggests Alo1’s FAD is covalently bound to His^X (some position), we can mutate that His to Ala and see if the purified mutant shows loss of covalent FAD (the flavin would likely not stay attached and might be washed out, yielding an apoenzyme). We can then reconstitute the mutant with free FAD to see if it binds non-covalently and retains any activity. This kind of experiment has been done in flavoprotein studies to confirm covalent link roles. A correct structural hypothesis will be supported if our mutations behave as predicted (e.g. His→Ala mutant binds FAD weakly and has drastically lower activity, showing that covalent tethering was important for function and stability[11]).
Through this comprehensive research plan, we will achieve a detailed characterization of alo1 in S. pombe: from its biochemical activity and product (D-erythroascorbate) to its role in cellular physiology and stress adaptation. The results will fill the gap in PomBase/UniProt’s experimental evidence for this gene, and they may reveal novel aspects of how eukaryotic cells protect and partition their mitochondria under oxidative duress. Moreover, understanding Alo1 in fission yeast could have broader implications – for example, if Alo1 is found to anchor mitochondria during stress, similar mechanisms might exist in other organisms or could be exploited in biotechnology (enhancing stress resistance of industrial yeasts by boosting erythroascorbate, etc.). In conclusion, our proposed experiments will not only confirm alo1’s expected function as a mitochondrial FAD-linked D-arabinono-1,4-lactone oxidase producing an ascorbate analog, but also rigorously investigate its cellular roles and mechanistic features, thereby significantly advancing the knowledge of this conserved yet under-studied gene.
Huh et al., 1998 – Molecular characterization of ALO1 in S. cerevisiae, showing it encodes D-arabinono-1,4-lactone oxidase needed for D-erythroascorbic acid synthesis and oxidative stress resistance[6][5].
KEGG/PomBase – Annotation of S. pombe alo1 (SPAPB1A10.12c) as D-arabinono-1,4-lactone oxidase and its role in ascorbate (aldarate) metabolism[1].
Cusabio/UniProt – Subcellular localization and family: Alo1 is a mitochondrial membrane protein, member of oxygen-dependent FAD oxidoreductases[12].
Boverio et al., 2024 – Structural and evolutionary analysis of aldonolactone oxidoreductases, noting fungi use ALO to produce an ascorbate analog and highlighting conserved mechanism and divergence (oxidase vs dehydrogenase)[2][16].
Chelius et al., 2025 – Discovery that yeast Alo1 (outer mitochondrial membrane) binds myosin V (Myo2) and is required for proper mitochondrial inheritance under stress[14].
Wu et al., 2022 (Journal of Fungi) – Functional study of Magnaporthe oryzae Alo1, showing that loss of Alo1 causes growth, conidiation, and virulence defects, and EASC supplementation rescues the phenotype[20][28]. These underscore the antioxidant role of Alo1 in fungal biology.
(Additional citations are embedded in the text above in 【】 format to supporting data from databases and literature.)
https://www.genome.jp/dbget-bin/www_bget?spo:2543430
[2] [7] [8] [16] [27] Structure, mechanism, and evolution of the last step in vitamin C biosynthesis | Nature Communications
[3] [12] Customize alo1 Antibody - Cusabio
https://www.cusabio.com/Custom-Antibodies/ALO-Antibody-12903496.html
[4] [5] [6] [11] [17] [23] D-Erythroascorbic acid is an important antioxidant molecule in Saccharomyces cerevisiae - PubMed
https://pubmed.ncbi.nlm.nih.gov/10094636/
[10] [20] [21] [22] [28] (PDF) A Putative D-Arabinono-1,4-lactone Oxidase, MoAlo1, Is Required for Fungal Growth, Conidiogenesis, and Pathogenicity in Magnaporthe oryzae
[13] [15] ALO1 D-arabinono-1,4-lactone oxidase [Saccharomyces cerevisiae S288C] - Gene - NCBI
https://www.ncbi.nlm.nih.gov/gene/854888
[14] [24] [25] A protein interaction map of the myosin Myo2 reveals a role for Alo1 in mitochondrial inheritance in yeast - PubMed
https://pubmed.ncbi.nlm.nih.gov/39775849/
[18] PomBase - GO biological process ontology term - metabolic process
https://www.pombase.org/term/GO:0008152
[19] [26] hughes.biochem.utah.edu
https://hughes.biochem.utah.edu/s/Sterol-Regulatory-Element-Binding-Protein.pdf